BioCentury
ARTICLE | Clinical News

99mTc-MIP-1404: Interim Phase II data

February 3, 2014 8:00 AM UTC

Interim data from 54 evaluable high-risk men with confirmed adenocarcinoma of the prostate who were scheduled for radical prostatectomy with extended pelvic lymph node dissection in an open-label, int...